Method of delivery of therapeutic metal ions, alloys and salts

Details for Australian Patent Application No. 2005309275 (hide)

Owner Inernational Bio-Therapeutic Research Inc.

Inventors Beal, Charles B.; Goldsmith, Robert; Rieder, Michael J.; Eagleson, Roy; Graber, Hollee D.; Babu, Uma Mahesh

Agent Davies Collison Cave

Pub. Number AU-A-2005309275

PCT Pub. Number WO2006/056055

Priority 60/629,975 23.11.04 US

Filing date 23 November 2005

Wipo publication date 1 June 2006

International Classifications

A61N 1/30 (2006.01) Electrotherapy - Apparatus for iontophoresis or cataphoresis

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 33/38 (2006.01) Medicinal preparations containing inorganic active ingredients - Silver

A61M 5/00 (2006.01) Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way

A61M 11/00 (2006.01) Sprayers

A61M 15/00 (2006.01) Inhaling devices

A61M 25/00 (2006.01) Catheters

A61M 37/00 (2006.01) Other apparatus for introducing media into the body

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/056055 Priority application(s): WO2006/056055

16 August 2007 Change of Name(s) of Applicant(s), Section 104

  Inernational Bio-Therapeutic Research Inc. The name of the applicant has been changed to International Biotherapeutic Research Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309278-Dental handpiece

2005309274-Treatment of cancer with a combination of an agent that perturbs the EGF signaling pathway and an oligonucleotide that reduces clusterin levels